Clinical trial of a formal group fatigue program in multiple sclerosis

C. L. Hugos, L. F. Copperman, B. E. Fuller, Vijayshree Yadav, J. Lovera, Dennis Bourdette

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Fatigue: Take Control is a novel program to teach fatigue management to people with multiple sclerosis (MS) following recommendations in the Fatigue and Multiple Sclerosis guideline. Fatigue: Take Control includes six 2-hour group sessions with DVD viewing, discussion and homework and accompanying participant and leader workbooks. While many people have participated in Fatigue: Take Control programs, its efficacy has not been determined. The objective of this study was to determine whether participation in Fatigue: Take Control reduces fatigue and increases self-efficacy in people with MS. Thirty participants were randomly assigned to a group who immediately participated in the program (FTC) or a wait-list group (WL). The primary outcome was the Modified Fatigue Impact Scale (MFIS) and secondary outcomes were the Multiple Sclerosis Self-Efficacy Scale (MSSE) and the Fatigue Severity Scale (FSS). The MFIS was administered on 10 occasions. Other measures were administered on four occasions. A mixed model tested the effects using all observations. Compared with the WL, the FTC group had significantly more improvement on the MFIS [F(1, 269) = 7.079, p = 0.008] and the MSSE [F(1, 111) = 5.636, p = 0.019]. No significant effect was found for the FSS. Across all visits, fatigue was significantly lower and self-efficacy was significantly higher for the FTC group compared with the WL group. This pilot study demonstrated significant effects in fatigue and self-efficacy among subjects taking the Fatigue: Take Control program, suggesting that this comprehensive program based on the Fatigue and Multiple Sclerosis guideline may be beneficial in MS.

Original languageEnglish (US)
Pages (from-to)724-732
Number of pages9
JournalMultiple Sclerosis
Volume16
Issue number6
DOIs
StatePublished - 2010

Fingerprint

Multiple Sclerosis
Fatigue
Clinical Trials
Self Efficacy
Guidelines

Keywords

  • Energy conservation
  • Exercise
  • Fatigue
  • Guideline
  • Multiple sclerosis
  • Quality of life
  • Rehabilitation
  • Self-efficacy
  • Symptom management

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Medicine(all)

Cite this

Clinical trial of a formal group fatigue program in multiple sclerosis. / Hugos, C. L.; Copperman, L. F.; Fuller, B. E.; Yadav, Vijayshree; Lovera, J.; Bourdette, Dennis.

In: Multiple Sclerosis, Vol. 16, No. 6, 2010, p. 724-732.

Research output: Contribution to journalArticle

Hugos, C. L. ; Copperman, L. F. ; Fuller, B. E. ; Yadav, Vijayshree ; Lovera, J. ; Bourdette, Dennis. / Clinical trial of a formal group fatigue program in multiple sclerosis. In: Multiple Sclerosis. 2010 ; Vol. 16, No. 6. pp. 724-732.
@article{5ff2173efa2c487cb21b8dc03641f081,
title = "Clinical trial of a formal group fatigue program in multiple sclerosis",
abstract = "Fatigue: Take Control is a novel program to teach fatigue management to people with multiple sclerosis (MS) following recommendations in the Fatigue and Multiple Sclerosis guideline. Fatigue: Take Control includes six 2-hour group sessions with DVD viewing, discussion and homework and accompanying participant and leader workbooks. While many people have participated in Fatigue: Take Control programs, its efficacy has not been determined. The objective of this study was to determine whether participation in Fatigue: Take Control reduces fatigue and increases self-efficacy in people with MS. Thirty participants were randomly assigned to a group who immediately participated in the program (FTC) or a wait-list group (WL). The primary outcome was the Modified Fatigue Impact Scale (MFIS) and secondary outcomes were the Multiple Sclerosis Self-Efficacy Scale (MSSE) and the Fatigue Severity Scale (FSS). The MFIS was administered on 10 occasions. Other measures were administered on four occasions. A mixed model tested the effects using all observations. Compared with the WL, the FTC group had significantly more improvement on the MFIS [F(1, 269) = 7.079, p = 0.008] and the MSSE [F(1, 111) = 5.636, p = 0.019]. No significant effect was found for the FSS. Across all visits, fatigue was significantly lower and self-efficacy was significantly higher for the FTC group compared with the WL group. This pilot study demonstrated significant effects in fatigue and self-efficacy among subjects taking the Fatigue: Take Control program, suggesting that this comprehensive program based on the Fatigue and Multiple Sclerosis guideline may be beneficial in MS.",
keywords = "Energy conservation, Exercise, Fatigue, Guideline, Multiple sclerosis, Quality of life, Rehabilitation, Self-efficacy, Symptom management",
author = "Hugos, {C. L.} and Copperman, {L. F.} and Fuller, {B. E.} and Vijayshree Yadav and J. Lovera and Dennis Bourdette",
year = "2010",
doi = "10.1177/1352458510364536",
language = "English (US)",
volume = "16",
pages = "724--732",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
number = "6",

}

TY - JOUR

T1 - Clinical trial of a formal group fatigue program in multiple sclerosis

AU - Hugos, C. L.

AU - Copperman, L. F.

AU - Fuller, B. E.

AU - Yadav, Vijayshree

AU - Lovera, J.

AU - Bourdette, Dennis

PY - 2010

Y1 - 2010

N2 - Fatigue: Take Control is a novel program to teach fatigue management to people with multiple sclerosis (MS) following recommendations in the Fatigue and Multiple Sclerosis guideline. Fatigue: Take Control includes six 2-hour group sessions with DVD viewing, discussion and homework and accompanying participant and leader workbooks. While many people have participated in Fatigue: Take Control programs, its efficacy has not been determined. The objective of this study was to determine whether participation in Fatigue: Take Control reduces fatigue and increases self-efficacy in people with MS. Thirty participants were randomly assigned to a group who immediately participated in the program (FTC) or a wait-list group (WL). The primary outcome was the Modified Fatigue Impact Scale (MFIS) and secondary outcomes were the Multiple Sclerosis Self-Efficacy Scale (MSSE) and the Fatigue Severity Scale (FSS). The MFIS was administered on 10 occasions. Other measures were administered on four occasions. A mixed model tested the effects using all observations. Compared with the WL, the FTC group had significantly more improvement on the MFIS [F(1, 269) = 7.079, p = 0.008] and the MSSE [F(1, 111) = 5.636, p = 0.019]. No significant effect was found for the FSS. Across all visits, fatigue was significantly lower and self-efficacy was significantly higher for the FTC group compared with the WL group. This pilot study demonstrated significant effects in fatigue and self-efficacy among subjects taking the Fatigue: Take Control program, suggesting that this comprehensive program based on the Fatigue and Multiple Sclerosis guideline may be beneficial in MS.

AB - Fatigue: Take Control is a novel program to teach fatigue management to people with multiple sclerosis (MS) following recommendations in the Fatigue and Multiple Sclerosis guideline. Fatigue: Take Control includes six 2-hour group sessions with DVD viewing, discussion and homework and accompanying participant and leader workbooks. While many people have participated in Fatigue: Take Control programs, its efficacy has not been determined. The objective of this study was to determine whether participation in Fatigue: Take Control reduces fatigue and increases self-efficacy in people with MS. Thirty participants were randomly assigned to a group who immediately participated in the program (FTC) or a wait-list group (WL). The primary outcome was the Modified Fatigue Impact Scale (MFIS) and secondary outcomes were the Multiple Sclerosis Self-Efficacy Scale (MSSE) and the Fatigue Severity Scale (FSS). The MFIS was administered on 10 occasions. Other measures were administered on four occasions. A mixed model tested the effects using all observations. Compared with the WL, the FTC group had significantly more improvement on the MFIS [F(1, 269) = 7.079, p = 0.008] and the MSSE [F(1, 111) = 5.636, p = 0.019]. No significant effect was found for the FSS. Across all visits, fatigue was significantly lower and self-efficacy was significantly higher for the FTC group compared with the WL group. This pilot study demonstrated significant effects in fatigue and self-efficacy among subjects taking the Fatigue: Take Control program, suggesting that this comprehensive program based on the Fatigue and Multiple Sclerosis guideline may be beneficial in MS.

KW - Energy conservation

KW - Exercise

KW - Fatigue

KW - Guideline

KW - Multiple sclerosis

KW - Quality of life

KW - Rehabilitation

KW - Self-efficacy

KW - Symptom management

UR - http://www.scopus.com/inward/record.url?scp=77953746351&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953746351&partnerID=8YFLogxK

U2 - 10.1177/1352458510364536

DO - 10.1177/1352458510364536

M3 - Article

VL - 16

SP - 724

EP - 732

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

IS - 6

ER -